This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Author: Avi Kapoor | June 21, 2024 12:28pm

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Oppenheimer analyst Brian Nagel upgraded the rating for NIKE, Inc. (NYSE:NKE) from Perform to Outperform, while raising the price target from $110 to $120. Nike shares gained 0.8% to close at $95.57 on Thursday. See how other analysts view this stock.
Morgan Stanley analyst Carlos De Alba upgraded Alcoa Corporation (NYSE:AA) from Equal-Weight to Overweight and boosted the price target from $36.5 to $50. Alcoa shares gained 4% to close at $38.98 on Thursday. See how other analysts view this stock.
RBC Capital analyst Shagun Singh upgraded the rating for Outset Medical, Inc. (NASDAQ:OM) from Sector Perform to Outperform, while increasing the price target from $5 to $6. Outset Medical shares fell 1.5% to settle at $3.5850 on Thursday. See how other analysts view this stock.
Morgan Stanley analyst Carlos De Alba upgraded Freeport-McMoRan Inc. (NYSE:FCX) from Equal-Weight to Overweight and boosted the price target from $49.5 to $62. Freeport-McMoRan shares gained 3.5% to close at $49.36 on Thursday. See how other analysts view this stock.
DA Davidson analyst Linda Bolton Weiser upgraded the rating for Prestige Consumer Healthcare Inc. (NYSE:PBH) from Neutral to Buy, while raising the price target from $65 to $93. Prestige Consumer shares settled at $65.28 on Thursday. See how other analysts view this stock.